Reassessing the Physiological Role of Gut-Specific Lymphocyte Homing: Implication
重新评估肠道特异性淋巴细胞归巢的生理作用:意义
基本信息
- 批准号:7852613
- 负责人:
- 金额:$ 265.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2013-09-30
- 项目状态:已结题
- 来源:
- 关键词:AntigensAutoimmune DiseasesCC chemokine receptor 7CCR9 geneDendritic CellsDiabetes MellitusFoodGenerationsHIVHomingImmune ToleranceImmune responseImmune systemIntegrinsIntestinal MucosaIntestinesLymphocyteMethodsMultiple SclerosisOralPhysiologicalProcessPsoriasisRegulatory T-LymphocyteResearchRheumatoid ArthritisRoleRotavirusSalmonella infectionsT-LymphocyteTretinoinTropismVaccinationVitamin AWorkabstractingmicrobialmigrationoral tolerancepublic health relevancereceptor
项目摘要
DESCRIPTION (Provided by the applicant)
Abstract: Oral immunological tolerance is an essential although poorly understood phenomenon by which the immune system becomes "non-responsive" against antigens administered via the intestinal mucosa. Although this process is vital for the co-existence with non-pathogenic intestinal antigens, such as food and normal microbial flora, the mechanisms responsible for oral tolerance remain poorly understood. Lymphocyte migration (homing) is essential for protective and pathological immune responses and we and others have demonstrated that gut-associated antigen-presenting dendritic cells instruct lymphocytes to express gut-specific homing receptors, integrin 4¿7 and chemokine receptor CCR9, by a mechanism dependent on the vitamin A metabolite retinoic acid (RA). Importantly, RA also contributes to the generation of regulatory T lymphocytes (TREG), which have been shown to be important for the establishment of oral tolerance. Given that RA induces gut-homing lymphocytes and also promotes TREG differentiation, I hypothesize that RA is essential for the establishment of oral tolerance i) by inducing gut-tropism and "sequestering" potentially pathogenic T lymphocytes in the intestinal mucosa and ii) by promoting TREG differentiation in the gut. If successful, my work will highlight a new physiological role of gut-homing in the establishment of oral tolerance, providing also a straightforward approach to induce immune tolerance using RA, which could be used in the treatment of autoimmune diseases.
Public Health Relevance: My research could provide a straightforward approach to treat autoimmune diseases, such as multiple sclerosis, diabetes, psoriasis and rheumatoid arthritis. It would also offer a simple method for boosting intestinal immune responses for vaccination purposes, such as in infections by Salmonella, rotavirus, and HIV.
描述(由申请人提供)
摘要:口服免疫耐受是一种重要的现象,尽管对其了解甚少,但免疫系统对通过肠粘膜施用的抗原变得“无应答”。虽然这一过程对于与非致病性肠道抗原(如食物和正常微生物植物群)共存至关重要,但对口服耐受性的机制仍知之甚少。淋巴细胞迁移(归巢)对于保护性和病理性免疫应答是必不可少的,我们和其他人已经证明,肠道相关抗原呈递树突状细胞通过依赖于维生素A代谢物视黄酸(RA)的机制指导淋巴细胞表达肠道特异性归巢受体,整合素4 <$7和趋化因子受体CCR 9。重要的是,RA还有助于调节性T淋巴细胞(Treg)的产生,其已被证明对于建立口服耐受性是重要的。鉴于RA诱导肠道归巢淋巴细胞,也促进TREG分化,我假设RA是建立口服耐受性所必需的i)通过诱导肠道嗜性和“隔离”肠粘膜中的潜在致病性T淋巴细胞和ii)通过促进肠道中的TREG分化。如果成功的话,我的工作将突出肠道归巢在建立口服耐受性中的新生理作用,也提供了一种直接的方法来诱导使用RA的免疫耐受性,这可用于治疗自身免疫性疾病。
公共卫生相关性:我的研究可以提供一种直接的方法来治疗自身免疫性疾病,如多发性硬化症,糖尿病,牛皮癣和类风湿性关节炎。它还将提供一种简单的方法来增强肠道免疫反应,用于疫苗接种,例如沙门氏菌,轮状病毒和艾滋病毒感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jorge Rodrigo Mora其他文献
Jorge Rodrigo Mora的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别:
Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 265.48万 - 项目类别: